Clinical Trials in Georgia

Showing 11361-11380 of 19,050 trials

Spatial Cognitive Training

NCT03423654

This study is designed to see if doing regular training on a spatial imagery task leads to improvements in the ability to do the trained spatial imagery task and in the ability to get around in everyday activities.

Blind

VA Office of Research and Development6 participantsStarted Mar 2018

Atlanta, Georgia, United States • Decatur, Georgia, United States

COMPLETEDPhase 365 miles

A Study Comparing Different Dosing Regimens of Ixekizumab (LY2439821) in Participants With Moderate to Severe Plaque Psoriasis

NCT02513550

The main purpose of this study is to evaluate the efficacy of ixekizumab dosing regimens in participants with plaque psoriasis.

Plaque Psoriasis

Eli Lilly and Company1,257 participantsStarted Aug 2015

Birmingham, Alabama, United States • Anaheim, California, United States • Beverly Hills, California, United States +122 more locations

Spatial Cognitive Training

A Study Comparing Different Dosing Regimens of Ixekizumab (LY2439821) in Participants With Moderate to Severe Plaque Psoriasis

Find Trials by Condition in Georgia

A Study of Baricitinib (LY3009104) in Participants With Moderate-to-Severe Atopic Dermatitis

Cognitive, Behavioral, and Functional Change in Behavioral Variant Frontotemporal Dementia (bvFTD)

A Neoadjuvant Study of Abemaciclib (LY2835219) in Postmenopausal Women With Hormone Receptor Positive, HER2 Negative Breast Cancer

A Study of Ixekizumab (LY2439821) in TNF Inhibitor Experienced Participants With Radiographic Axial Spondyloarthritis

Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis

A Study of Mirikizumab (LY3074828) in Participants With Moderate to Severe Ulcerative Colitis

A Safety Study of Galcanezumab in Participants With Migraine, With or Without Aura

Phase 1b DV281 With an Anti-PD-1 Inhibitor in NSCLC

Evaluation of Myocardial Effects of MTP-131 for Reducing Reperfusion Injury in Patients With Acute Coronary Events

Different Doses of BI 1467335 Compared to Placebo in Patients With Clinical Evidence of NASH

Registry to Evaluate INOmax in Newborn Babies With Pulmonary Hypertension

Phase 2 Study of Triheptanoin (UX007) for the Treatment of Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)

Quetiapine SR and Divalproex Sodium ER in the Treatment of Anxiety in Bipolar Disorder With Panic Disorder and/or GAD

A Gene Therapy Study for Hemophilia B

Ofatumumab Added to Fludarabine-Cyclophosphamide vs Fludarabine-Cyclophosphamide Combination in Relapsed Subjects With Chronic Lymphocytic Leukemia

A Study of the Natural History of Leukocyte Chemotactic Factor 2 Amyloidosis (ALECT2) Disease

Temsirolimus Adventitial Delivery to Improve Angiographic Outcomes Below the Knee (TANGO)

Dorzolamide-timolol in Combination With Anti-vascular Endothelial Growth Factor Injections for Wet Age-related Macular Degeneration